sefulness of Homoeopathic medicine in Bipolar affective disoder
Phase 2
- Conditions
- Health Condition 1: F31- Bipolar disorder
- Registration Number
- CTRI/2024/01/061059
- Lead Sponsor
- Dr Aiswarya J
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Ages from 18 to 65 years, both sexes who have fulfilled the DSM V criteria for Bipolar 1 disorder.
2.Bipolar 1 disorder with or without psychotic symptoms
Exclusion Criteria
1. Patients with suicidal risks,
2. Pregnant and lactating women,
3. Chronic severe Medical Illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cases will be assessed with Born Steiner Irritability scale (BSIS), and Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD)Timepoint: The Born Steiner Irritability scale (BSIS) will be used to assess the cases at the Baseline and every month till the conclusion of the study. <br/ ><br>The Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD) will be used to assess the cases at the Baseline and every three months till the conclusion of the study.
- Secondary Outcome Measures
Name Time Method The reduction in frequency of episodes of irritability in Bipolar 1 disorder will be assessed using Born Steiner Irritability scale (BSIS).Timepoint: Cases will be assessed with Born Steiner Irritability scale (BSIS), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.;The reduction in intensity of irritability in subsequent episodes of Bipolar 1 disorder will be assessed using Born Steiner Irritability scale (BSIS).Timepoint: Cases will be assessed with Born Steiner Irritability scale (BSIS), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.;The reduction of symptoms of Bipolar 1 disorder will be assessed using SAEBD scale.Timepoint: Cases will be assessed with Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.